ClinVar Miner

Submissions for variant NM_000340.2(SLC2A2):c.59G>A (p.Gly20Asp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003324353 SCV004028616 likely pathogenic Fanconi-Bickel syndrome 2023-07-25 criteria provided, single submitter clinical testing Variant summary: SLC2A2 c.59G>A (p.Gly20Asp) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251128 control chromosomes. To our knowledge, no occurrence of c.59G>A in individuals affected with Fanconi-Bickel syndrome has been reported. At least one publication reports experimental evidence evaluating an impact on protein function showing lack of expression of the protein resulting in decrease of glucose transport(Michau_2013). The following publication have been ascertained in the context of this evaluation (PMID: 23986439). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.